A Surgical Window of Opportunity Clinical Trial of Troriluzole in Recurrent IDH Wild-Type Glioblastoma

Clinical trial NCT06552260 · RECRUITING

Trial details

NCT number: NCT06552260
Sponsor: Ugonma Chukwueke
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Glioblastoma Recurrent Glioblastoma Brain Tumor

Start date: 2025-02-19
Primary completion: 2026-08-01
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.